The global Cell & Gene Therapy Manufacturing Services Market was valued at USD 11.4 billion in 2023 and is projected to reach USD 70.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.4% over the forecast period from 2024 to 2032. The rising demand for cell and gene therapies, coupled with the increasing trend of outsourcing manufacturing services, is expected to drive significant growth in this market.

Market Overview

Cell and gene therapies represent a rapidly growing sector of the biopharmaceutical industry, offering groundbreaking treatments for a variety of genetic and chronic diseases. These therapies are highly complex and require specialized manufacturing processes. With many companies opting to outsource manufacturing to contract development and manufacturing organizations (CDMOs), the market for cell and gene therapy manufacturing services is expanding rapidly.

Get A Free Sample Report on Cell & Gene Therapy Manufacturing Services Market @ https://www.snsinsider.com/sample-request/ 1187

Key Market Drivers

  • Rising Demand for Advanced Therapies: The growing focus on cell and gene therapies to treat conditions such as cancer, genetic disorders, and autoimmune diseases is a major driver for the market. With numerous therapies in development and clinical trials, the demand for efficient and scalable manufacturing services is expected to grow.

  • Outsourcing Manufacturing to CDMOs: Given the complexity of manufacturing cell and gene therapies, many biopharmaceutical companies are choosing to outsource production to specialized CDMOs. Outsourcing provides companies with access to advanced manufacturing capabilities without the need for heavy capital investments, accelerating time-to-market.

  • Technological Advancements in Manufacturing Processes: Continuous innovations in bioprocessing and manufacturing technologies, including automation and scalable production platforms, are driving improvements in the production of cell and gene therapies. These advancements are expected to increase the efficiency and scalability of manufacturing services.

  • Regulatory Support and Approvals: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are providing accelerated approval pathways for cell and gene therapies, encouraging the development of more advanced therapeutic solutions and fueling the demand for specialized manufacturing services.

Key Segments:

By Therapy Type

  • Cell therapy manufacturing

    • Stem cell therapy

    • Non stem cell therapy

  • Gene therapy manufacturing

By Manufacturing Scale

  • Pre-commercial/R&D scale manufacturing

  • Commercial scale manufacturing

By Manufacturing Mode

  • Contract Manufacturing

  • In-house manufacturing

By Workflow

  • Cell processing

  • Cell banking

  • Process development

  • Fill & finish operations

  • Analytical and quality testing

  • Raw material testing

  • Vector production

  • Others

Key Players

  • Cellular Therapeutics

  • Lonza

  • Bluebird Bio Inc.

  • Thermo Fisher Scientific

  • Samsung Biologics

  • Boehringer Ingelheim

  • Hitachi Chemical Co., Ltd.

  • Takara Bio Inc.

  • Catalent Inc.

  • Miltenyi Biotec

  • F. Hoffmann-La Roche Ltd

  • Novartis AG

  • Merck KGaA

  • Wuxi Advanced Therapies and others.

Conclusion

The cell and gene therapy manufacturing services market is expected to experience exponential growth, driven by the increasing adoption of advanced therapies, outsourcing trends, and ongoing technological advancements. As the demand for specialized manufacturing services continues to rise, the market offers lucrative opportunities for industry players in the coming yearS


Make an inquiry on the Cell & Gene Therapy Manufacturing Services Market Report @ https://www.snsinsider.com/enquiry/ 1187

TABLE OF CONTENT 

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Therapy Type  

8. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Manufacturing Scale   

9. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Manufacturing Mode

10. Cell & Gene Therapy Manufacturing Services Market Segmentation, By Workflow

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion


Buy a Single-User PDF of Cell & Gene Therapy Manufacturing Services Market @ https://www.snsinsider.com/checkout/ 1187

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)